146 related articles for article (PubMed ID: 17211556)
1. Serum protease inhibitor concentrations and total antitrypsin activity in diabetic and non-diabetic children during adolescence.
Lisowska-Myjak B; Pachecka J; Kaczyńska B; Miszkurka G; Kadziela K
Acta Diabetol; 2006 Dec; 43(4):88-92. PubMed ID: 17211556
[TBL] [Abstract][Full Text] [Related]
2. Antigenic and functional levels of alpha-1-antitrypsin in serum during normal and diabetic pregnancy.
Lisowska-Myjak B; Pachecka J
Eur J Obstet Gynecol Reprod Biol; 2003 Jan; 106(1):31-5. PubMed ID: 12475578
[TBL] [Abstract][Full Text] [Related]
3. Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus.
Hashemi M; Naderi M; Rashidi H; Ghavami S
Diabetes Res Clin Pract; 2007 Feb; 75(2):246-8. PubMed ID: 16875754
[TBL] [Abstract][Full Text] [Related]
4. Alteration of plasma proteinase-antiproteinase system in type 1 diabetic patients. Influence of sex and relationship with metabolic control.
Finotti P; Piccoli A; Carraro P
Diabetes Res Clin Pract; 1992 Oct; 18(1):35-42. PubMed ID: 1280191
[TBL] [Abstract][Full Text] [Related]
5. Alpha-1-antitrypsin and IgA in serial meconium and faeces of healthy breast-fed newborns.
Lisowska-Myjak B; Pachecka J
Fetal Diagn Ther; 2007; 22(2):116-20. PubMed ID: 17135756
[TBL] [Abstract][Full Text] [Related]
6. An association between Type 2 diabetes and alpha-antitrypsin deficiency.
Sandström CS; Ohlsson B; Melander O; Westin U; Mahadeva R; Janciauskiene S
Diabet Med; 2008 Nov; 25(11):1370-3. PubMed ID: 19046232
[TBL] [Abstract][Full Text] [Related]
7. Serum alpha-1-antitrypsin concentration during normal and diabetic pregnancy.
Lisowska-Myjak B; Sygitowicz G; Wolf B; Pachecka J
Eur J Obstet Gynecol Reprod Biol; 2001 Nov; 99(1):53-6. PubMed ID: 11604186
[TBL] [Abstract][Full Text] [Related]
8. Serum trypsin inhibitory capacity in normal pregnancy and gestational diabetes mellitus.
Yaghmaei M; Hashemi M; Shikhzadeh A; Mokhtari M; Niazi A; Ghavami S
Diabetes Res Clin Pract; 2009 Jun; 84(3):201-4. PubMed ID: 19344972
[TBL] [Abstract][Full Text] [Related]
9. Functional activities and nonenzymatic glycosylation of plasma proteinase inhibitors in diabetes.
Hall P; Tryon E; Nikolai TF; Roberts RC
Clin Chim Acta; 1986 Oct; 160(1):55-62. PubMed ID: 2429788
[TBL] [Abstract][Full Text] [Related]
10. Serum alpha 1-protease inhibitor in diabetes mellitus: reduced concentration and impaired activity.
Sandler M; Gemperli BM; Hanekom C; Kühn SH
Diabetes Res Clin Pract; 1988 Oct; 5(4):249-55. PubMed ID: 3266137
[TBL] [Abstract][Full Text] [Related]
11. Studies of protease inhibitors in the sera of patients with amyotrophic lateral sclerosis.
Adachi N; Shoji S
J Neurol Sci; 1989 Feb; 89(2-3):165-8. PubMed ID: 2466958
[TBL] [Abstract][Full Text] [Related]
12. Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.
Weir GC; Ehlers MR; Harris KM; Kanaparthi S; Long A; Phippard D; Weiner LJ; Jepson B; McNamara JG; Koulmanda M; Strom TB;
Pediatr Diabetes; 2018 Aug; 19(5):945-954. PubMed ID: 29473705
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three methods for the determination of serum alpha-1-antitrypsin in patients with pulmonary diseases.
Prinsen JH; Schweisfurth H; Rasche B; Breuer J
Clin Physiol Biochem; 1989; 7(3-4):198-202. PubMed ID: 2509124
[TBL] [Abstract][Full Text] [Related]
14. High serum leptin levels in children with type 1 diabetes mellitus: contribution of age, BMI, pubertal development and metabolic status.
Luna R; Garcia-Mayor RV; Lage M; Andrade MA; Barreiro J; Pombo M; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1999 Nov; 51(5):603-10. PubMed ID: 10594521
[TBL] [Abstract][Full Text] [Related]
15. Serum antiproteases in smokers and nonsmokers. Relationships to smoking status and pulmonary function.
Bridges RB; Kimmel DA; Wyatt RJ; Rehm SR
Am Rev Respir Dis; 1985 Dec; 132(6):1162-9. PubMed ID: 3878111
[TBL] [Abstract][Full Text] [Related]
16. Comparison of alpha 1- antitrypsin activity and phenotype in type 1 diabetic patients to healthy individuals.
Ghoreishi AS; Mahmoodi M; Khoshdel A
J Family Med Prim Care; 2022 Apr; 11(4):1377-1381. PubMed ID: 35516706
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes.
Martinez MT; Ramos O; Carretero N; Calvillán M; Gutierrez-López MD; Cuesta P; Serrano-Ríos M
Diabete Metab; 1994; 20(5):454-7. PubMed ID: 7859892
[TBL] [Abstract][Full Text] [Related]
18. α1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population.
Bornhorst JA; Greene DN; Ashwood ER; Grenache DG
Chest; 2013 Apr; 143(4):1000-1008. PubMed ID: 23632999
[TBL] [Abstract][Full Text] [Related]
19. [Antithrombin III, alpha 2-macroglobulin, alpha 1-antitrypsin and plasminogen in childhood diabetes].
Kotschy M; Wasikowa R; Iwanicka Z; Ciosek W
Pol Tyg Lek; 1984 Apr; 39(18):611-3. PubMed ID: 6085653
[No Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
